. . . . . september 2013 (21) .marketwatch: "new migraine drugs have promise -- and a ,500 price tag." .of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met. . http://lm360.us/Romansky-neighbour-of-Floto-from-Ume?Dewittdau=290 .